Swiss Pharma’s BPC-157 TB-500 SKU is a co-formulated research blend in one prefilled pen — not two separate vials, and not a “stack” marketed for recovery or sports use.
For research use only. Not for human or veterinary use. Not intended to diagnose, treat, cure, or prevent any disease. See /policies/research-use.
What’s in the pen
| Spec | Value |
|---|---|
| Page name | BPC-157 TB-500 Blend |
| Fill | 20 mg total (10 mg + 10 mg) |
| Format | Prefilled 3 mL pen, bacteriostatic water |
| Concentration | 6.67 mg/mL |
| Storage | Refrigerate 2–8 °C; keep upright; do not freeze; in-use up to 30 days after first use — discard if particulates form |
Identity from live product description (research context only): BPC-157 is a 15-amino-acid pentadecapeptide; TB-500 is a synthetic fragment of thymosin beta-4. Both appear in published animal-model literature. This article does not claim tissue repair, healing, or any therapeutic effect.
Lot checks
- Confirm format is the co-formulated pen on the product page.
- Match pen lot / QR to the Certificate of Analysis.
- Confirm HPLC and MS documentation for that lot (/science).
What we kill on purpose
- Recovery or sports framing
- Vial language for this SKU
- Dosage or titration schedules in this article
- Medical or veterinary use
Next steps
- Product: /product/bpc-157-tb-500
- Catalog: /catalog
- COA primer: /journal/research-peptides-uae-coa